DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
S. H. P. van de Pavert(Multiple Sclerosis Society), Olga Ciccarelli(Queen Mary University of London), Alan J. Thompson(Queen Mary University of London), Nils Muhlert(Manchester Academic Health Science Centre), Gerard R. Ridgway(Wellcome Centre for Human Neuroimaging), Jeroen J.G. Geurts(Amsterdam Neuroscience), Declan Chard(National Institute for Health and Care Research), Varun Sethi(MRC Prion Unit), David H. Miller(National Hospital for Neurology and Neurosurgery), María A. Ron(University of London), Tarek Yousry(National Hospital for Neurology and Neurosurgery), Claudia A. M. Gandini Wheeler‐Kingshott(Queen Mary University of London)
Cited by 46
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
|NeuroImage|2006|6.6k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k